Skip to content
ClinCalc Pro
Menu
Adrenaline (Epinephrine) — Sympathomimetic Pregnancy: UK SPC §4.6: 'A teratogenic effect has been demonstrated in animal studies. Adrenaline crosses the placenta. There is some evidence of a slightly increased incidence of congenital abnormalities. Injection of adrenaline may cause anoxia, fetal tachycardia, cardiac irregularities, extra systoles and louder heart sounds. Adrenaline usually inhibits spontaneous or oxytocin induced contractions of the uterus and may delay the second stage of labour. In dosage sufficient to reduce uterine contractions, the drug may cause a prolonged period of uterine atony with haemorrhage. For this reason, parenteral adrenaline should not be used during the second stage of labour. Adrenaline should only be used during pregnancy if the potential benefits outweigh the possible risks to the fetus.' BREAST-FEEDING: 'Adrenaline is distributed into breast milk. Breast-feeding should be avoided in mothers receiving adrenaline injection.' FERTILITY: no data available.

Adrenaline IM (Paediatric — Anaphylaxis)

Brand names: EpiPen Jr (150 mcg), Jext 150 mcg, Emerade 150 mcg

This page covers intramuscular adrenaline as the first-line treatment of anaphylaxis in children, delivered into the anterolateral thigh.

Adult dose

Dose: Anaphylaxis: 0.5 mg (500 micrograms) intramuscularly — 0.5 mL of adrenaline 1 mg/ml (1:1000)
Route: Intramuscular — 'The best site for IM injection is the anterolateral aspect of the middle third of the thigh'
Frequency: 'If necessary, this dose may be repeated several times at 5-minute intervals according to blood pressure, pulse and respiratory function'
VERBATIM §4.2 (Adults): 'The usual dose is 0.5 mg (0.5ml of adrenaline 1mg/ml (1:1000)).' Route rationale, VERBATIM: 'The intramuscular (IM) route is recommended by the EU Resuscitation Council as the most appropriate for most individuals who have to give adrenaline to treat an anaphylactic reaction... The subcutaneous route for adrenaline is not recommended for treatment of an anaphylactic reaction as it is less effective.' 'The needle used for injection needs to be sufficiently long to ensure that the adrenaline is injected into muscle.' ROUTE WARNING, VERBATIM: 'Do not give Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection intravenously. Intravenous administration of adrenaline for anaphylaxis requires the use of a 1:10,000 adrenaline solution.' maxDose left empty deliberately: the SPC states a usual dose that may be repeated, and gives no dose ceiling with an explicit maximum cue. ELDERLY: 'There are no specific dosage regimes for adrenaline injection in elderly patients. However, Adrenaline should be used with great caution in these patients who may be more susceptible to the cardiovascular side effects of adrenaline.' Administration by a trained healthcare professional.

Paediatric dose

Route: Intramuscular — anterolateral aspect of the middle third of the thigh
Frequency: May be repeated several times at 5–15 minute intervals according to blood pressure, pulse and respiratory function
Concentration: 1 mg/ml
dosePerKg is null deliberately: the SPC's paediatric anaphylaxis regimen is AGE-BANDED with fixed milligram doses, and the only per-kilogram figure it gives (0.01 mg/kg) applies to infants under 6 months ONLY — it is not valid across the paediatric range, so it must not drive a weight calculator. VERBATIM §4.2 'Paediatric population — The following doses of Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection are recommended: Over 12 years 0.5 mg IM (0.5ml 1mg/ml (1:1000) solution) [0.3 mg IM (0.3ml) if the child is small or pre-pubertal]; 6 - 12 years 0.3 mg IM (0.3ml 1mg/ml (1:1000) solution); 6 months - 6 years 0.15 mg IM (0.15ml 1mg/ml (1:1000) solution); Under 6 months 0.01mg/kg IM (0.01ml/kg 1mg/ml (1:1000) solution). If necessary, these doses may be repeated several times at 5 - 15 minutes intervals according to blood pressure, pulse and respiratory function. A small volume syringe should be used.' concentration = 1 because the source product is adrenaline 1 mg/ml (1:1000) — 1 mg per mL. maxDose left empty deliberately: no dose ceiling is stated with an explicit maximum cue; 0.5 mg is the over-12 band dose, not a declared maximum. DO NOT give this 1:1000 strength intravenously. Auto-injector devices are not dosed in this SPC. Verify any under-18 dose against a children's formulary before administration.

Dose adjustments

Renal

No renal dose adjustment is given in the fetched sections. §4.4 lists severe renal impairment among the conditions in which adrenaline should be used with caution, and notes that prolonged administration may induce metabolic acidosis, renal necrosis and tachyphylaxis.

Hepatic

Not stated — the fetched UK SPC sections contain no hepatic impairment dosing statement.

Dose independently re-sourced from UK Summary of Product Characteristics (SPC) via the eMC — clinician-reviewed. Always confirm against the product SmPC and your local formulary before prescribing.

Contraindications

  • Hypersensitivity to the active substance or to any of the excipients — but note the SPC's own qualifier, VERBATIM §4.3: 'Contraindications are relative as this product is intended for use in life-threatening emergencies.'
  • Use in fingers, toes, ears, nose, genitalia or buttocks owing to the risk of ischaemic tissue necrosis (§4.3)
  • Do not use if the solution is discoloured (§4.3)
  • Do not give the 1 mg/ml (1:1000) solution intravenously — §4.2/§4.4: intravenous administration of adrenaline for anaphylaxis requires a 1:10,000 (0.1 mg/ml) solution

Side effects

  • Cardiac: palpitations, tachycardia; in high dosage or in sensitive patients — cardiac dysrhythmia (sinus tachycardia, ventricular fibrillation/cardiac arrest), acute angina attacks and risk of acute myocardial infarction (§4.8)
  • Vascular: pallor, coldness of the extremities; in high dosage or in sensitive patients — hypertension (with risk of cerebral haemorrhage) and vasoconstriction, for example cutaneous, in the extremities or kidneys (§4.8)
  • Nervous system: headache, tremors, dizziness, syncope; in patients with Parkinsonian syndrome adrenaline increases rigidity and tremor (§4.8)
  • Psychiatric: anxiety, nervousness, fear, hallucinations (§4.8)
  • Metabolic: hyperglycaemia, hypokalaemia, metabolic acidosis (§4.8)
  • Gastrointestinal: nausea, vomiting (§4.8)
  • Respiratory: dyspnoea (§4.8)
  • Eye: mydriasis (§4.8)
  • General: sweating, weakness; repeated local injections may produce necrosis at sites of injection as a result of vascular constriction (§4.8)
  • All the above are listed at 'Frequency not known' in the SPC — the occurrence of undesirable effects depends on the sensitivity of the individual patient and the dose involved

Monitoring

  • VERBATIM §4.2: 'The patient should be monitored as soon as possible (pulse, blood pressure, ECG, pulse oximetry). This will help monitor the response to adrenaline.'
  • §4.4: 'This product is for emergency use only and medical supervision of the patients is necessary after administration.'
  • Blood glucose — §4.4: 'Adrenaline may cause or exacerbate hyperglycaemia, blood glucose should be monitored, particularly in diabetic patients.'
  • Inspect the injection site — repeated local administration may produce necrosis at the sites of injection (§4.4)

Clinical monograph

How it works

Adrenaline stimulates alpha- and beta-adrenoceptors, reversing anaphylaxis by causing vasoconstriction, bronchodilatation, reduced mucosal oedema and increased cardiac output.

Prescribing in practice

  • In a child with suspected anaphylaxis, give intramuscular adrenaline into the anterolateral thigh without delay using the weight- or age-appropriate dose from a children's formulary, and repeat after a few minutes if there is no improvement.
  • The intramuscular route is preferred; intravenous adrenaline is reserved for specialist resuscitation settings because of arrhythmia risk.
  • Position the child appropriately, give high-flow oxygen and call for help, as adrenaline is part of a wider resuscitation algorithm.

Monitoring

Monitor airway, breathing, circulation, oxygen saturation and conscious level continuously, and observe after recovery for a biphasic reaction.

Counselling the patient

  • Adrenaline is the most important emergency treatment for a severe allergic reaction.
  • After treatment the child must be observed in hospital because symptoms can return.
  • Carers should be trained in auto-injector technique and when to call for emergency help.

Evidence & guidelines

UK Resuscitation Council and NICE guidance position intramuscular adrenaline as the immediate first-line treatment for anaphylaxis at all ages.

Reference: Resuscitation Council UK Anaphylaxis Guidelines 2021; BSACI; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.